Mononucleosis Diagnostic Market Trends and Scope by 2031
Mononucleosis Diagnostic Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 151.44 Million |
Market Size by 2031 | US$ 222.15 Million |
Global CAGR (2023 - 2031) | 4.9% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Mononucleosis Diagnostic Market News and Recent Developments
The mononucleosis diagnostic market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Below is a key development witnessed in the mononucleosis diagnostic market:
- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, along with SD Biosensor, Inc. and SJL Partners LLC, has announced the completion of their acquisition of Meridian. (Source: Meridian Bioscience, Inc. Website, January 2024)
Mononucleosis Diagnostic Market Report Coverage and Deliverables
The "Mononucleosis Diagnostic Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Mononucleosis diagnostic market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Mononucleosis diagnostic market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Mononucleosis diagnostic market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the mononucleosis diagnostic market
- Detailed company profiles